Many Heads - One Mission

Your Health!

Department & Team

Prof. Dr. med. Constantin Roder

Phone: +49 7071 29 0
E-Mail: constantin.roder@med.uni-tuebingen.de

Akademische Laufbahn

  • Studium der Humanmedizin (Vorklinik) an der Semmelweis Universität, Budapest (2004-2006)
  • Studium der Humanmedizin (Klinik) an der Eberhard Karls Universität, Tübingen (2006-2010)
  • Forschungspraktikum YALE Neurogenetics Laboratory, YALE University, School of Medicine, New Haven, Ct., USA (2009)
  • Promotion: “Common Genetic Polymorphisms in Moyamoya and Atherosclerotic Disease” (2010)
  • Beginn der Facharztausbildung an der Neurochirurgischen Universitätsklinik Tübingen (2011)
  • Clinical Fellwoship mit dem Schwerpunkt der intraoperativen MRT Bildgebung, Washington University, St. Louis, MO., USA (2012)
  • Facharztbezeichnung Neurochirurgie (2017)
  • Habilitation im Fach Neurochirurgie "Intraoperative MRI in Neurosurgery: Technical developments, indications and impact on the treatment of patients" (2017)
  • Clinical Fellowship mit dem Schwerpunkt Vaskuläre und Schädelbasischirurgie, University of Cinicinatti, OH., USA (2017)
  • Ernennung zum Oberarzt der Neurochirurgischen Universitätsklinik Tübingen (2017)
  • Geschäftsführender Oberarzt der Neurochirurgischen Universitätsklinik Tübingen (2019)
  • Außerplanmäßige Professur (2020)
  • Leitender Oberarzt Bereich Vaskuläre Neurochirurgie (2020)

Wissenschaftliche Interessen

  • Moyamoya
  • Intraoperative MRT Bildgebung und Navigation
  • Neurochirurgische Onkologie
  • Genetik neurovaskulärer Erkrankungen

Publikationen


  • Zerweck L, Hauser TK, Roder C, Blazhenets G, Khan N, Ernemann U, Meyer PT, Klose U. (2023) Evaluation of the cerebrovascular reactivity in patients with Moyamoya Angiopathy by use of breath-hold fMRI: investigation of voxel-wise hemodynamic delay correction in comparison to [15O]water PET. Neuroradiology. 2023 Mar;65(3):539-550
  • Güresir E, Lampmann T, Brandecker S, Czabanka M, Fimmers R, Gempt J, Haas P, Haj A, Jabbarli R, Kalasauskas D, König R, Mielke D, Németh R, Oppong MD, Pala A, Prinz V, Ringel F, Roder C, Rohde V, Schebesch KM, Wagner A, Coch C, Vatter H. (2022) PrImary decompressive Craniectomy in AneurySmal Subarachnoid hemOrrhage (PICASSO) trial: study protocol for a randomized controlled trial. Trials. 2022 Dec 20;23(1):1027
  • Fröhlich E, Sassenrath C, Nadji-Ohl M, Unteroberdörster M, Rückriegel S, von der Brelie C, Roder C, Forster MT, Schommer S, Löhr M, Pala A, Goebel S, Mielke D, Gerlach R, Renovanz M, Wirtz CR, Onken J, Czabanka M, Tatagiba MS, Rohde V, Ernestus RI, Vajkoczy P, Gansland O, Coburger J. (2022) Resilience in Lower Grade Glioma Patients. Cancers (Basel). 2022 Nov 2;14(21):5410
  • Akeret K, Buzzi RM, Saxenhofer M, Bieri K, Chiavi D, Thomson BR, Grüttner-Durmaz M, Schwendinger N, Humar R, Regli L, van Doormal TPC, Held U, Keller E, Hugelshofer M, Schaer DJ, HeMoVal research group (Roder C), (2022) BMC Neurol, Jul 18;22(1):267
  • Güresir E, Lampmann T, Bele S, Czabanka M, Czorlich P, Gempt J, Goldbrunner R, Hurth H, Hermann E, Jabbarli R, Krauthausen M, König R, Lindner D, Malinova V, Meixensberger J, Mielke D, Németh R, Darkwah Oppong M, Pala A, Prinz V, Rashidi A, Roder C, Sandalcioglu IE, Sauvigny T, Schebesch KM, Timmer M, Vajkoczy P, Wessels L, Wild F, Wilhelm C, Wostrack M, Vatter H, Coch C. (2022) Fight INflammation to Improve outcome after aneurysmal Subarachnoid HEmorRhage (FINISHER) trial: Study protocol for a randomized controlled trial. Int J Stroke, Feb;18(2):242-247
  • Coburger J, Onken J, Rueckriegel S, von der Brelie C, Nadji-Ohl M, Forster MT, Gerlach R, Unteroberdörster M, Roder C, Kniese K, Schommer S, Rothenbacher D, Nagel G, Wirtz CR, Ernestus RI, Nabavi A, Tatagiba M, Czabanka M, Ganslandt O, Rohde V, Löhr M, Vajkoczy P, Pala A. (2022) Eloquent Lower Grade Gliomas, a Highly Vulnerable Cohort: Assessment of Patients' Functional Outcome After Surgery Based on the LoG-Glio Registry. Front Oncol, Mar 3;12:845992
  • Haas P, Fudali M, Wang SS, Hurth H, Hauser TK, Ernemann U, Tatagiba M, Khan N, Roder C. (2021) Quality of life impairment in adult Moyamoya patients-preoperative neuropsychological assessment and correlation to MRI and H215O PET findings. Neurosurg Rev. Apr;45(2):1533-1541
  • Zerweck L, Roder C, Hauser TK, Thurow J, Mengel A, Tatagiba M, Khan N, Meyer PT, Ernemann U, Klose U. (2021) Hemodynamic evaluation of patients with Moyamoya Angiopathy: comparison of resting-state fMRI to breath-hold fMRI and [15O]water PET. Neuroradiol. Mar;64(3):553-563
  • Brendle C, Maier C, Bender B, Schittenhelm J, Paulsen F, Renovanz M, Roder C, Castaneda-Vega S, Tabatabai G, Ernemann U, la Fougère C. (2021) Impact of 18F-FET PET/MR on clinical management of brain tumor patients. J Nucl Med. Apr;63(4):522-527
  • Hurth H, Hauser TK, Haas P, Wang S, Mengel A, Tatagiba M, Ernemann U, Khan N, Roder C. (2021) Early Post-operative CT-Angiography Imaging After EC-IC Bypass Surgery in Moyamoya Patients. Front Neurol.Mar 25;12:655943
  • Hurth H, Steiner J, Birkenhauer U, Roder C, Hauser TK, Ernemann U, Tatagiba M, Ebner FH. (2021) Relationship of the vascular territory affected by delayed cerebral ischemia and the location of the ruptured aneurysm in patients with aneurysmal subarachnoid hemorrhage. Neurosurg Rev. Dec;44(6):3479-3486
  • Roder C, Klose U, Hurth H, Brendle C, Tatagiba M, Ernemann U, Khan N, Hauser TK (2021) Longitudinal reproducibility of CO2-triggered BOLD MRI for the hemodynamic evaluation adult patients with Moyamoya Angiopathy. Cerebrovascular Diseases, epub ahead of print
  • Roder C, Haas P, Tatagiba M, Ernemann U, Bender B. (2020) Technical limitations and pitfalls of diffusion-weighted imaging in intraoperative high-field MRI. Neurosurg Rev. 2021 Feb;44(1):327-334.
  • Roder C, Haas P, Fudali M, Milian M, Ernemann U, Meyer PT, Tatagiba M, Khan N. (2020) Neuropsychological impairment in adults with moyamoya angiopathy: preoperative assessment and correlation to MRI and H215O PET. Neurosurg Rev, 43(6):1615-1622
  • Gohla G, Bender B, Tatagiba M, Honegger J, Ernemann U, Roder C. (2020) Identification of tumor residuals in pituitary adenoma surgery with intraoperative MRI: do we need gadolinium? Neurosurg Rev, 43(6):1623-1629
  • Scherer M, Ahmeti H, Roder C, Gessler F, Jungk C, Pala A, Mayer B, Senft C, Tatagiba M, Synowitz M, Wirtz CR, Unterberg AW, Coburger J. (2019) Surgery for Diffuse WHO Grade II Gliomas: Volumetric Analysis of a Multicenter Retrospective Cohort From the German Study Group for Intraoperative Magnetic Resonance Imaging. Neurosurgery, 1;86(1):E64-E74
  • Pala A, Nadji-Ohl M, Faust K, Rückriegel S, Roder C, von der Brelie C, Forster MT, Löbel F, Schommer S, Löhr M, Grübel N, Rothenbacher D, König R, Engelke J, Schmitz B, Wirtz CR, Senft C, Rohde V, Tatagiba M, Ernestus RI, Vajkoczy P, Ganslandt O, Nagel G, Coburger J. (2020) Multicentric Registry Study on Epidemiological and Biological Disease Profile as Well as Clinical Outcome in Patients with Low-Grade Gliomas: The LoG-Glio Project.J Neurol Surg A, 81(1):48-57
  • Paľa A, Coburger J, Scherer M, Ahmeti H, Roder C, Gessler F, Jungk C, Scheuerle A, Senft C, Tatagiba M, Synowitz M, Wirtz CR, Schmitz B, Unterberg AW. (2019) To treat or not to treat? A retrospective multicenter assessment of survival in patients with IDH-mutant low-grade glioma based on adjuvant treatment. J Neurosurg. 19:1-8
  • Roder C, Hauser TK, Ernemann U, Tatagiba M, Khan N, Bender B. (2019) Arterial wall contrast enhancement in progressive moyamoya disease. J. Neurosurg. 24:1-9
  • Bier G, Klumpp B, Roder C, Garbe C, Preibsch H, Ernemann U, Hempel JM. (2019) Meningeal enhancement depicted by magnetic resonance imaging in tumor patients: neoplastic meningitis or therapy-related enhancement? Neuroradiology. 61(7):775-782.
  • Hauser TK, Seeger A, Bender B, Klose U, Thurow J, Ernemann U, Tatagiba M, Meyer PT, Khan N, Roder C. (2019) Hypercapnic BOLD MRI compared to H215O PET/CT for the hemodynamic evaluation of patients with Moyamoya Disease. Neuroimage Clin. 2019;22:101713
  • Roder C, Burkle E, Ebner FH, Tatagiba M, Ernemann U, Buck A, et al. (2018) Estimation of severity of moyamoya disease with [(15)o]water-positron emission tomography compared with magnetic resonance imaging and angiography . World Neurosurg. 2018;117:e75-e81
  • Skardelly M, Monch L, Roder C, Hockel K, Tatagiba MS, Ebner FH.(2018) Survey of the management of perioperative bridging of anticoagulation and antiplatelet therapy in neurosurgery . Acta Neurochir (Wien). 2018 Nov;160(11):2077-2085.
  • Breitkopf M, Bisdas S, Liebsch M, Behling F, Bender B, Tatagiba M, Roder C. (2017) Safety, utility, and clinical results of continuous intraoperative electrophysiologic monitoring in 1.5t imri-guided surgery. World Neurosurg. 2017;106:198-205
  • Roder C, Breitkopf M, Bisdas S, da Silva Freitas R, Dimostheni A, Ebinger M, Wolff M, Tatagiba M, Schuhmann M. (2016) Beneficial impact of high-field intraoperative MRI on effectivity of pediatric low-grade glioma surgery. Neurosurg Focus 40:E13, 2016
  • Coburger J, Merkel A, Scherer M, Schwartz F, Gessler F, Roder C, Pala A, König R, Bullinger L, Nagel G, Jungk C, Bisdas S, Nabavi A, Ganslandt O, Seifert V, Tatagiba M, Senft C, Mehdorn M, Unterberg AW, Rössler K, Wirtz CR. (2015) Low-Grade Glioma Surgery in Intraoperative Magnetic Resonance Imaging I: Results of a Multicenter Retrospective Assessment of the German Study Group for Intraoperative Magnetic Resonance Imaging. Neurosurgery.78(6):775-86
  • Roder C, Charyasz-Leks E, Breitkopf M, Decker K-H, Ernemann U, Klose U, Tatagiba M, Bisdas S. (2015) Resting-state functional MR imaging in an intraoperative MRI setting: Proof of feasibility and correlation to clinical outcome of patients. J Neurosurg 1:1-9, 2016
  • Bisdas S, Charyasz-Leks E, Roder C, Tatagiba MS, Ernemann U, Klose U. (2015) Evidence of Resting-state Activity in Propofol-anesthetized Patients with Intracranial Tumors. Acad Radiol. 2016 Feb;23(2):192-199
  • Bisdas S, Roder C, Ernemann U, Tatagiba MS.(2015) Intraoperative MR Imaging in Neurosurgery. Clin Neuroradiol. 2015;25 Suppl 2:237-244
  • Ebner FH, Roser F, Roder C, Tatagiba M, Schuhmann MU.(2015) Rigid, Variable-View Endoscope in Neurosurgery: First Intraoperative Experience. Surg Innov. 22(4):390-3
  • Roder C, Bisdas S, Ebner FH, Honegger J, Naegele T, Ernemann U, Tatagiba M. (2013) Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: High-field iMRI versus conventional and 5-ALA-assisted surgery. European Journal of Surgical Oncology, 40(3):297-304.
  • Liu W, Senevirathna ST, Hitomi T, Kobayashi H, Roder C, Herzig R, Kraemer M, Voormolen MH, Cahová P, Krischek B, Koizumi A. (2013) Genomewide association study identifies no major founder variant in Caucasian moyamoya disease. Journal of Genetics, 92(3):605-9.
  • Roder C, Skardelly M, Bender B, Ramina Fingerle K, Honegger J, Nägele T, Tatagiba M, Ernemann U, Bisdas S. (2013) Spectroscopy imaging in intraoperative MR suite: Tissue characterization and optimization of tumor resection. International Journal of Computer Assisted Radiology and Surgery, 9(4):551-9.
  • Bisdas S, Koh TS, Roder C, Braun C, Schittenhelm J, Ernemann U, Klose U (2013) Intravoxel incoherent motion diffusion-weighted MR imaging of gliomas: feasibility of the method and initial results., Neuroradiology, 55(10):1189-96.
  • Roder C, Bisdas S, Tatagiba M (2013) The Tübingen Experience with VISUS Surgical Theatre. Hospital Healthcare Europe, Theatre and Surgery, 1:17-19
  • Roder C, Bender B, Ritz R, Honegger J, Feigl G, Naegele T, Tatagiba M, Ernemann U, Bisdas S (2012) Intraoperative Visualization of Residual Tumor: The Role of Perfusion-Weighted Imaging in a High-Field Intraoperative MR Scanner. Neurosurgery,72:ons151-158
  • Liu C#, Roder C#, Schulte C, Kasuya H, Akagawa H, Nishizawa T, Yoneyama T, Okada Y, Khan N, Tatagiba M, Berg D, Krischek B (2012) Analysis of TGFB1 in European and Japanese Moyamoya Disease Patients. European Journal of Medical Genetics, Eur J Med Genet. 55:531-4. #authors contributed equally
  • Roder C, Ebner F, Schuhmann M (2012) Neurenteric cysts of the cerebellopontine angle. Journal of Neurological Surgery A, 74 Suppl 1:e36-40
  • Roder C, Kasuya H, Harati A, Tatagiba M, Inoue I, Krischek B (2012) Meta-analysis of microarray gene expression studies on intracranial aneurysms. Neuroscience201:105-13.
  • Kraemer M, Horn PA, Roder C, Khan N, Diehl RR, Berlit P, Heinemann FA (2012) Analysis of human leucocyte antigen genes in Caucasian patients with idiopathic Moyamoya angiopathy. Acta Neurochirurgica, 154:445-54
  • Krischek B, Kasuya H, Khan N, Tatagiba M, Roder C, Kraemer M (2011) Genetic and clinical characteristics of Moyamoya disease in Europeans. Trends in Neurovasc Surg, Acta Neurochir Suppl 112:31-34
  • Roder C, Nayak NR, Khan N, Tatagiba M, Inoue I, Krischek B (2010) Genetics of Moyamoya disease. Journal of Human Genetics 55: 711-716
  • Roder C, Peters V, Kasuya H, Nishizawa T, Wakita S, Berg D, Schulte C, Khan N, Tatagiba M, Krischek B (2010) Analysis of ACTA2 in European Moyamoya disease patients. European Journal of Paediatric Neurology15(2):117-22
  • Roder C, Peters V, Kasuya H, Nishizawa T, Takehara Y, Berg D, Schulte C, Khan N, Tatagiba M, Krischek B (2010) Polymorphisms in TGFB1and PDGFRB are associated with Moyamoya disease in European patients. Acta Neurochirurgica (Wien) 152: 2153-2160
  • Roder C, Peters V, Kasuya H, Nishizawa T, Takehara Y, Berg D, Schulte C, Khan N, Tatagiba M, Krischek B (2010) Common genetic polymorphisms in Moyamoya and atherosclerotic disease in Europeans. Childs Nervous System 27(2):245-52
  • Yasuno K, Bilguvar K, Bijlenga P, Low S-K, Krischek B, Auburger G, Simon M, Krex D, Arlier Z, Nayak N, Ruigrok YM, Niemela M, Tajima A, von und zu Fraunberg M, Doczi T, Wirjatijasa F, Hata A, Blasco J, Oszvald A, Kasuya H, Zilani G, Schoch B, Singh P, Stuer C, Risselada R, Beck J, Sola T, Ricciardi F, Aromaa A, Illig T, Schreiber S, van Duijn CM, van den Berg LH, Perret C, Proust C, Roder C, Ozturk AK, Gaal E, Berg D, Geisen C, Friedrich CM, Summers P, Frangi AF, State MW, Wichmann HE, Breteler MMB, Wijmenga C, Mane S, Peltonen L, Elio V, Sturkenboom MCJM, Lawford P, Byrne J, Macho J, Sandalcioglu EI, Meyer B, Raabe A, Steinmetz H, Rufenacht D, Jaaskelainen JE, Hernesniemi J, Rinkel GJE, Zembutsu H, Inoue I, Palotie A, Cambien F, Nakamura Y, Lifton RP, Gunel M (2010) Genome-wide association study of intracranial aneurysm identifies three new risk loci. Nature Genetics 42: 420-425

Buchkapitel

  • Roder C, Hurth H. Clivuschordom – Neurologische Fallbesprechungen: Neuroonkologie, G. Tabatabai, Kohlhammer Verlag, 2022
  • Hoffmann E, Roder C. Optikusgliom bei Neurofibromatose Typ I - Neurologische Fallbesprechungen: Neuroonkologie, G. Tabatabai, Kohlhammer Verlag, 2022
  • Müther M, Stummer W, Tatagiba M, Roder C. Essentials Neurochirurgie. Neurologische Fallbesprechungen: Neuroonkologie, G. Tabatabai, Kohlhammer Verlag, 2022
  • Roder C, Khan N. Moyamoya Erkrankung – Pädiatrische Neurochirurgie H. Bächli et al., Springer, 2018
  • Krämer M, Khan N, Diesner F, Roder C. Moyamoya-Syndrom und Moyamoya-Erkrankung – Informationen für Betroffene, Angehörige und Interessierte – Deutscher Medizinbuchverlag 2014
  • Roder C, Krischek B Genetics of Moyamoya Angiopathy in Wanebo JE, Khan N, Zabramski JM, Spetzler RF,Moyamoya Disease – Diagnosis and treatment, Thieme 2013

Kongressbeiträge

  • Haas P, Fudali M, Hurth H, Wang S, Tatagiba M, Khan N, Roder C. (2022) Quality of life and neuropsychological outcome after EC-IC bypass revascularisation in adult Moyamoya patients. DGNC Jahrestagung, Köln
  • Wang S, Hurth H, Haas P, Ernemann U, Tatagiba M, Bender B, Khan N, Roder C (2022) Predictive value of quantified vessel wall contrast enhancement to monitor disease progression in Moyamoya Angiopathy. DGNC Jahrestagung, Köln
  • Wang S, Bender B, Ernemann U, Khan N, Tatagiba M, Roder C (2022) Incidence of vessel-wall contrast-enhancement in Moyamoya-Angiopathy (MMA). DGNC Jahrestagung, Köln
  • Wang S,Hurth H, Haas P, Bender B, Ernemann U, Tatagiba M, Khan N, Roder C (2021). Quantification of vessel wall contrast enhancement to monitor disease progression in Moyamoya Disease. DGNC Sektionswoche, Göttingen
  • Roder C, Hauser TK, Hurth H, Wang S, Haas P, Ernemann U, Tatagiba M, Khan N (2021) Longitudinal reproducibility of CO2-triggered BOLD MRI for the hemodynamic evaluation of patients with Moyamoya Angiopathy. EANS Jahrestagung, Hamburg
  • Wang S,Hurth H, Haas P, Bender B, Ernemann U, Tatagiba M, Khan N, Roder C (2021). Quantification of vessel wall contrast enhancement to monitor disease progression in Moyamoya Disease . EANS Jahrestagung, Hamburg
  • Hurth H, Hauser TK, Haas P, Wang S, Ernemann U, Tatagiba M, Khan N, Roder C. (2021) Clinical value of early postoperative CT-angiography imaging after EC-IC Bypass in patients with moyamoya. DGNC Jahrestagung, Erfurt
  • Roder C, Hauser TK, Hurth H, Wang S, Haas P, Ernemann U, Tatgiba M, Khan N. (2021) Longitudinal reproducibility of CO2-triggered BOLD MRI for the hemodynamic evaluation of patients with Moyamoya Angiopathy . DGNC Jahrestagung, Erfurt
  • Haas P, Fudali M, Hurth H, Wang S, Tatgiba M, Khan N, Roder C (2021) Quality of life in adult Moyamoya patients – preoperative assessment and correlation to MRI and H215O-PET findings . DGNC Jahrestagung, Erfurt
  • Wang S, Hurth H, Haas P, Bender B, Ernemann U, Tatagiba M, Khan N, Roder C. (2021) Vessel wall contrast enhancement as sign of disease progression in Moyamoya Disease. DGNC Jahrestagung, Erfurt
  • Roder C. Intraoperative Visualisierung: 5-ALA und intraoperatives MRT (2021) NOA Jahrestagung, Tübingen
  • Wang S, Haas P, Hurth H, Tatagiba M, Khan N, Roder C. Vessel wall contrast enhancement as sign of disease progression in Moyamoya Disease (2020) DGNC Jahrestagung, Lübeck
  • Haas P, Hurth H, Wang S, Tatagiba M, Fusali M, Khan N, Roder C. Quality of life in adult Moyamoya patients – preoperative assessment and correlation to MRI and H215O-PET findings. (2020) DGNC Jahrestagung, Lübeck
  • Roder C , Hurth H, Haas P, Hauser TK, Tatagiba M, Khan N. Longitudinale Vergleichbarkeit des CO2-getriggerten BOLD MRT für die hämodynamische Evaluation bei Moyamoya Patienten . (2020) DGNC Jahrestagung, Lübeck
  • Roder C , Hurth H, Haas P, Hauser TK, Tatagiba M, Khan N. Longitudinale Vergleichbarkeit des CO2-getriggerten BOLD MRT für die hämodynamische Evaluation bei Moyamoya Patienten. (2020) Sektionstagung vaskuläre NCH, Frankfurt a.M.
  • Hurth H, Haas P, Hauser TK, Tatagiba M, Khan N, Roder C (2020) Nutzen der postoperativen CTA Bildgebung nach direktem EC-IC Bypass bei Moyamoya Patienten (2020) Sektionstagung vaskuläre NCH, Frankfurt a.M.
  • Roder C, Hauser TK,Ernemann U, Meyer P, Tatagiba M, Khan N (2019) Arterial Wall Contrast Enhancement in Progressive Moyamoya Disease. 70. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie, Würzburg, Deutschland
  • Roder C, Hauser TK, Ernemann U, Meyer P, Tatagiba M, Khan N (2019) CO2-triggered BOLD MRI for the hemodynamic evaluation of patients with Moyamoya Disease. 70. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie, Würzburg, Deutschland
  • Roder C (2019) iMRI & 5-ALA Clinical Review; Useful or Overtreatment? 7th Biannial meeting of the intraoperative imaging society, Houston, Tx., USA
  • Roder C (2018) Spectroscopy and Perfusion Imaging in ioMRI: Optimization of Tumor resection. Hybrid OR Symposium, Berlin, Germany
  • Roder C (2018) Speech Mapping and ioMRI: Current status and Future Developments. Hybrid OR Symposium, Berlin, Germany
  • Roder C (2018) Moyamoya bei Erwachsenen - Diagnose, Behandlun und Follow-up. 24. Fortibildungsakademie für seltene Erkrankungen (FAKSE) des ZSE Tübingen, Tübingen
  • Roder C (2018) Moyamoya - Allgemeines, Ätiologie, Stand der Forschung. 24. Fortibildungsakademie für seltene Erkrankungen (FAKSE) des ZSE Tübingen, Tübingen
  • Roder C, Tatagiba M (2018) Use of ioNM during iMRI - is it practical? (2018) 3rd Global IMRIS User Meeting, Tampa, FL, USA
  • Roder C, Tatagiba M (2018) iMRI and 5-ALA. Useful tool or overtreatment? (2018) 3rd Global IMRIS User Meeting, Tampa, FL, USA
  • Roder C, Tatagiba M, Bender B (2018) Optimization of Diffusion-Weighted IMaging (DWI) in intraoperative MRI (iMRI). 69. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie, Münster, Deutschland
  • Roder C, Buck F, Meyer P, Ernemann U, Tatagiba M, Khan N (2017) Differences between results of angiography, MRI and H2[(15)O]-PET with acetazolamide challenge in the evaluation of the cerebral perfusion of patients with Moyamoya . 68. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie, Magdeburg, Deutschland
  • Roder C, Hockel K, Schuhmann MU, Hempel J, Ernemann U, Tatagiba M (2017) Endovascular treatment of Benign Intracranial Hypertension caused by venous stenosis: Indications, treatment success and analysis of the literature. 68. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie, Magdeburg, Deutschland
  • Roder C, Breitkopf M, Bisdas S, Liebsch M, Behling F, Tatagiba M (2017) Safety, value, and feasibility of continuous intraoperative electrophysiological monitoring in 1.5T iMRI-guided surgery . 68. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie, Magdeburg, Deutschland
  • Roder C, Tatagiba M, Bisdas S (2017) Feasibility, initial results and future aspects of intraoperative resting-state fMRI . 6th Biannial meeting of the intraoperative imaging society, Hannover, Germany
  • Roder C, Breitkopf M, Bisdas S, Liebsch M, Behling F, Tatagiba M (2017) Safety, value, and feasibility of continuous intraoperative electrophysiological monitoring in 1.5T iMRI-guided surgery . 6th Biannial meeting of the intraoperative imaging society, Hannover, Germany
  • Roder C , Ebner F, Hockel K, Tatagiba M, Khan N (2016) Presentation and management of intracranial aneurysms associated with Moyamoya . Poster, 67. Jahrestagung der deutschen Gesellschaft für Neurochirurgie, Frankfurt a.M., Deutschland
  • Roder C , Ebner F, Tatagiba M, Khan N (2016) Stroke prevention in Moyamoya – experience of 179 multiple vascular territory revascularizations in 5 years . 67. Jahrestagung der deutschen Gesellschaft für Neurochirurgie, Frankfurt a.M., Deutschland
  • Roder C, Breitkopf M, Bisdas S, Dimostheni A, Tatagiba M, Schuhmann MU (2016) Beneficial impact of high-field intraoperative MRI on effectivity of pediatric low-grade glioma surgery. 67. Jahrestagung der deutschen Gesellschaft für Neurochirurgie, Frankfurt a.M., Deutschland
  • Roder C, Ebner F, Deanovic D, Baltsavias G, Khan N (2016) Neurosurgical management in pediatric moyamoya: experience of 139 cerebral revascularizations. ESPN 2016, Paris, France
  • Roder C, Bisdas S (2015) Resting-state functional MR imaging for sensorimotor networks in an iMRI setting: Proof of feasibility and correlation to clinical outcome of patients. 66. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie, 7.-10. Juni 2015, Karlsruhe
  • Roder C, István Csók, Florian Ebner, Gerasimos Baltsavias, Ulrike Ernemann,
    Marcos Tatagiba, Nadia Khan (2015) Posterior circulation involvement in European moyamoya angiopathy: Presentation and management 66. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie, 7.-10. Juni 2015, Karlsruhe
  • Roder C, Bisdas S (2015) Funktionelle Bildgebung im intraoperativen MRT. Sektionstagung Endoskopische Neurochirurgie, Neuronavigation und intraoperatvie Bildgebung 2015, 27.-28. März 2015, Erfurt
  • Roder C, Tatagiba M (2014) Critical View on the indications of IMRI in skull-base surgery. 22. Jahrestagung der Gesellschaft für Schädelbasischirurgie GSB, 6.-8. November 2014, Wien, Österreich
  • Roder C (2014) Welche Daten braucht der Neurochirurg? 49. Jahrestagung der dt. Gesellschaft für Neurochirurgie, Köln, 23.-25. Oktober 2014
  • Roder C, Bisdas S (2014) Intraoperative MRT, Aufwand, Nutzen, Potential 49. Jahrestagung der dt. Gesellschaft für Neurochirurgie, Köln, 23.-25. Oktober 2014
  • Roder C (2014) _Maximizing the extent of resection in glioblastoma surgery: 5-ALA versus intraoperative MRI 2nd Int.IMRIS user meeting, Minneapolis Sept 11-13
  • Roder C, Breitkopf M, Dimostheni A, Bisdas S, Tatagiba M, Schuhmann MU (2014) Intraoperative MRI-guidance in pediatric low grade glioma surgery – Advantages and challenges, Presentation, DGNC Jahrestagung, Dreseden, 2014
  • Roder C, Bisdas S, Charyasz E, Klose U, Tatagiba M (2014) Reproducible evidence of resting-state functional MRI in anesthetized patients with intracranial lesions in an intraoperative MRI, DGNC Jahrestagung, Dreseden, 2014
  • Roder C, Breitkopf M, Dimostheni A, Bisdas S, Tatagiba M, Schuhmann MU (2014) Intraoperative MRI-guidance in pediatric low grade glioma surgery – Advantages and challenges, Presentation, Sektionstagung pädiatrische Neurochirurgie, Münster 2014
  • Roder C, Bisdas S, Tatagiba M (2014) Intraoperative MRT Bildgebung bei der Resektion von Glioblastomen: iMRI vs. 5-ALA, Presentation, Sektionstagung Endoskopische Neurochirurgie, Neuronavigation und intraoperative Bildgebung der DGNC, Stuttgart, 7.-8. März 2014.
  • Roder C, Bisdas S, Tatagiba M (2013) Die Bedeutung des intraoperativen MRTs bei der Resektion von Clivuschordomen Presentation, 21. Jahrestagung der Gesellschaft für Schädelbasischirurgie (GSB) in Tübingen 2013.
  • Tatagiba M, Bisdas S, Roder C (2013) Moveable High-Field iMRI: Tool or toy? Presentation, 64th meeting of the Scandinavian Neurosurgical Society & 38th meeting of the Nordic Society of Neuroradiology, Harpa Reykjavík, Iceland 5 – 8 June 2013.
  • Bisdas S, Roder C, Ritz R, Honegger J, Naegele T, Ernemann U, Tatagiba M (2013) Perfusion-weighted imaging in the intraoperative MR suite: feasibility and influence on maximisation of the tumour resection. Presentation, 64. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie, Düsseldorf
  • Roder C, Bisdas S, Tatagiba M (2013) Maximizing the extent of resection in glioblastoma surgery: 5-ALA versus intraoperative MRI. Presentation, 64. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie, Düsseldorf
  • Roder C, Bisdas S, Tatagiba M , Honegger J (2013) Surgical therapy of large pituitary adenomas with a 1.5 Tesla intraoperative MRI. Presentation, 64. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie, Düsseldorf
  • Roder C, Bisdas S, Tatagiba M (2013) Resection of recurrent glioblastomas: Can iMRI improve results? Presentation, 64. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie, Düsseldorf
  • Roder C, Bisdas S, Tatagiba M (2013) Maximizing the extent of resection in glioblastoma surgery: 5-ALA versus iMRI.St. Louis, MO, USA. 4th Biennial Meeting Intraoperative Imaging Society (IOIS) February 24-27, 2013
  • Tatagiba M, Roder C (2012) High field – iMRI in Skull Base Tumors. Presentation, National Congress of the Italian Skull Base Society; Novara, November 29, 2012.
  • Roder C (2012) High grade glioma surgery in a high-field iMRI – Improvement of the extent of resection? Presentation, 2nd International IMRI Symposium Tübingen, September 27-28, 2012.
  • Roder C (2012) Genetische und andere Ursachen für das Moyamoya Syndrom. Präsentation, Moyamoya Informationsforum für Patienten Essen, 8. September 2012
  • Tatagiba, M, Roder, C (2012) First Experience with Mobile intraoperative MR system in Tuebingen, Germany.Presentation, 12th Annual Meeting of the Japan intraoperative imaging society July 7th 2012, Tsukuba, Japan
  • Roder C, Liu C, Schulte C, Kasuya H, Akagawa H, Nishizawa T, Yoneyama T, Okada Y, Khan N, Tatagiba M, Berg D, Krischek B (2012) Analysis of TGFB1 in European and Japanese Moyamoya Disease Patients. Presentation, 63. Jahrestagung der deutschen Gesellschaft für Neurochirurgie, Leipzig 2012
  • Gugel I, Feigl GC, Roder C, Roser F, Bornemann A, Tatagiba M, Krischek B (2012) The formation of sporadic vestibular schwannomas: microarray gene expression analysis reveals the role of NFAT and T-cell response. Presentation, 63. Jahrestagung der deutschen Gesellschaft für Neurochirurgie, Leipzig 2012
  • Heinemann F, Roder C, Khan N, Diehl R, Berlit P, Horn P, Kraemer M (2012) Analysis of human leukocyte antigens in Caucasians with Moyamoya angiopathy. Poster, Annual meeting of the European Federation for Immunogegentics,EFI, Liverpool 2012
  • Tatagiba, M, Roder, C (2012) Intraoperative Imaging in Neurosurgery: Tool or Toy? Presentation, 44th International Diagnostic Course March 25-30, 2012, Davos, Switzerland
  • Roder C, Krischek B (2011) Genetics and the term Moyamoya. Vortrag, Invited speaker, 2nd International Moyamoya meeting, Zürich 2011
  • Krischek B, Gugel I, Pantazis G, Bornemann A, Roder C, Feigl GC, Roser F, Schuhmann MU, Bonin M, Tatagiba M (2011) Microarray based comparison of Neurofibromatosis Type 2 associated vestibular schwannomas show an over-expression of TSPAN8 compared to the sporadic form. Poster, 62. Jahrestagung der deutschen Gesellschaft für Neurochirurgie (DGNC), Hamburg 7.-11. Mai 2011
  • Roder C, Ebner F, Schuhmann M (2010) Endoskopisch-assistierte Resektion neurenterischer Zysten des Kleinhirnbrückenwinkels mit variabler Morphologie. Poster, 18 Jahrestagung der Deutschen Gesellschaft für Schädelbasischirurgie (DGSB) 1/2 Oktober 2010
  • Krischek B, Roder C, Peters V, Kasuya H, Nishizawa T, Takehara Y, Berg D, Schulte C, Feigl G, Khan N, Tatagiba M (2010) Common genetic polymorphisms in Moyamoya and atherosclerotic disease in Europeans. Vortrag, 61 Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC) im Rahmen der Neurowoche 2010 Joint Meeting mit der Brasilianischen Gesellschaft für Neurochirurgie am 20 September 2010
  • Krischek B, Bilguvar K, Yasuno K, M S, Krex D, Auburger G, Berg D, Schulte C, Roder C, Schoch B, Sandalcioglu, Stüer C, Meyer B, Oszvald A WF, Geisen C, Beck J, Raabe A, Illig T, Schreiber S, Lifton R, Günel M (2009)Susceptibility loci for intracranial aneurysms found in the German Population. Vortrag, Jahrestagung der Sektion Vaskuläre Neurochirurgie der Deutschen Gesellschaft für Neurochirurgie (DGNC), Genf, 24 und 25 April 2009
  • Krischek B, Roder C, Kasuya H, Inoue I, Tatagiba M (2008) The etiology of subarachnoid haemorrhage: Genetic predisposition, environmental factors or inflammation? Poster, XVII European Stroke Conference Nice, France, May 13-16, 2008

Auszeichnungen

  • Bester Vortrag der Sektionstagung pädiatrische Neurochirurgie 2014 in Münster
    Intraoperative MRI-guidance in pediatric low grade glioma surgery – Advantages and challenges.
  • 3. Posterpreis auf der 21. Jahrestagung der Gesellschaft für Schädelbasischirurgie (GSB) in Tübingen 2013 Value of iMRI-guided surgery for large osteo-destructive skull-base tumors)
  • 1. Posterpreis auf der 18. Jahrestagung der Deutschen Gesellschaft für Schädelbasischirurgie (DGSB) in Erfurt 2010 (Endoskopisch-assistierten Resektion neurenterischer Zysten des Kleinhirnbrückenwinkels mit variabler Morphologie)

External Publicationdatabase

Alle Publikationen finden Sie auch in der externen Publikationsdatenbank. Ein Service der “U.S. National Library of Medicine” und dem “National Institutes of Health”

External Publicationdatabase
©2023 Neurochirurgie Uniklinik Tübingen - All rights reserved
Created with Pixelizer - Creative Media Design